Ethics top priority for US biotechnology, says retiring head
The retiring head of the US biotechnology association believes that ethics is the main issue which could derail his industry. “We have paid passionate attention to bioethics issues,” Carl Feldbaum told the Seattle Times. “We have taken them dead seriously. We have gone beyond narrow commercial interests and have tried to contribute, without commandeering, debates about Dolly, stem cells and gene therapy… The mishandling of a bioethics issue could derail us in no time, but hopefully that won’t happen.”
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
China accused of sequencing Tibetan and Uyghur DNA to supply organ transplant market
A committee of the US Congress has heard shocking testimony about alleged forced organ harvesting from Uyghurs and Falun Gong...
European Parliament describes surrogacy as a form of human trafficking
The European Parliament has described “the exploitation of surrogacy” as a form of human trafficking in a legislative resolution on...
‘Forced surrogacy’ reported in the UK
A British charity working with victims of modern slavery has reported that it had received three reports of “forced surrogacy” for the...
We should react to atrocities in Gaza, says bioethicists
The war between Israel and Hamas in Gaza is creating tensions within the bioethics community. In an article in the...
Quadriplegic Quebec man chooses assisted dying rather than live with bedsores
A quadriplegic Quebec man has chosen assisted dying because of a bedsore he acquired when a hospital failed to give...
Transgender medicine critic Hilary Cass given police protection
The author of the recent review of Britain’s gender identity services for children and young people has told The Times (of London)...